Search Login Register
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
(CPP)
Summary
Description:
structure given in first source; NMDA receptor antagonist
Also Known As:
CPP; 3-2-CPP; 4-(3-phosphonopropyl)-2-piperazinecarboxylic acid
Networked: 1908
relevant articles (118 outcomes,
295 trials/studies)
for this Bio-Agent
Key Diseases for which 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid is
Relevant
-
Pelvic Pain
:
15 outcomes 39 studies in 272 results
-
Pain (Aches)
:
12 outcomes 32 studies in 180 results
-
Precocious Puberty
:
9 outcomes 32 studies in 302 results
-
Endometriosis (Adenomyosis)
:
6 outcomes 14 studies in 58 results
-
Neoplasms (Cancer)
:
6 outcomes 10 studies in 144 results
Show All >>
Drugs Related to 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
-
Gonadotropin-Releasing Hormone (GnRH)
-
Morphine (MS Contin)
-
N-Methylaspartate (NMDA)
-
Carbon Monoxide
-
maleic acid (maleate)
-
Oxygen
-
Caseins (Casein)
-
Dextrorphan
-
Dizocilpine Maleate (Dizocilpine)
-
Ketamine
Show All >>
Therapies Related to 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
-
Cardiopulmonary Resuscitation (CPR)
-
Resuscitation
-
Injections
-
Hemodilution
-
Phototherapy (Light Therapy)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.